Vancouver, British Columbia / TheNewswire / January 26, 2018 – CBD Med Research Corp. (NEX: CBM.H) (the “Company”) has requested to resume trading.

The “Company” had recently identified a business target and requested a Halt Trading of its Securities. Upon conducting further due diligence, management has determined to not proceed with the transaction and has requested a resumption to trade.

 

Management reports, at this time the “Company” and its Technical Advisors are evaluating various business opportunities.

 

On Behalf of The Board,

“Gary F. Zak”

Gary F. Zak, Chief Executive Officer

For further information, please contact: Gary Zak gzak1@shaw.ca or 604-802-7551

 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as such term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

Cautionary Notes Regarding Forward-looking Statements

This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation (collectively “forward-looking statements”). Certain information contained herein constitutes “forward-looking information” under Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “expects”, “will”, “intend”, “is expected to”, “anticipates” and variations of such words and phrases or statements that certain actions, events or results “will” occur. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made and they are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed by such forward-looking statements.